Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:43:24.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH’s website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content. It appears above the page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-26T14:48:18.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision advances from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:39:16.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:43:49.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the previous content with an access-denied screen, indicating the record is not accessible at this time.
    Difference
    18%
    Check dated 2026-09-21T21:49:16.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, signaling a small update to the page. This likely reflects back-end or formatting adjustments rather than changes to study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-31T17:41:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.